1. Home
  2. PRME vs RRBI Comparison

PRME vs RRBI Comparison

Compare PRME & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.16

Market Cap

553.2M

Sector

Health Care

ML Signal

N/A

Logo Red River Bancshares Inc.

RRBI

Red River Bancshares Inc.

N/A

Current Price

$101.98

Market Cap

613.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
PRME
RRBI
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
553.2M
613.0M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
PRME
RRBI
Price
$3.16
$101.98
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$7.56
N/A
AVG Volume (30 Days)
2.7M
39.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
1.07%
EPS Growth
18.18
28.89
EPS
N/A
3.59
Revenue
$4,632,000.00
N/A
Revenue This Year
$7.06
$12.72
Revenue Next Year
$47.01
$4.35
P/E Ratio
N/A
$28.61
Revenue Growth
55.28
N/A
52 Week Low
$2.67
$61.60
52 Week High
$6.94
$104.84

Technical Indicators

Market Signals
Indicator
PRME
RRBI
Relative Strength Index (RSI) 40.43 55.35
Support Level $2.73 $98.35
Resistance Level $3.72 $103.92
Average True Range (ATR) 0.21 1.80
MACD -0.06 -0.04
Stochastic Oscillator 11.63 58.92

Price Performance

Historical Comparison
PRME
RRBI

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: